Literature DB >> 9393621

Lack of emodin genotoxicity in the mouse micronucleus assay.

U Mengs1, G Krumbiegel, W Völkner.   

Abstract

The study was performed to investigate the potential of emodin (1,3,8-trihydroxy-6-methylanthraquinone) to induce micronuclei in polychromatic erythrocytes (PCEs). Mice of both genders received a single oral dose of 2000 mg emodin/kg and were killed 24 and 48 h later. Bone marrow cells were collected from 5 males and 5 females and 2000 PCEs per animal were scored for the presence of micronuclei. There was no enhancement in the frequency of micronuclei at both preparation intervals when compared to the negative controls. Blood level examinations confirmed the systemic availability of emodin. Plasma levels of up to 190 micrograms emodin/ml represented concentrations being in the concentration range that induced positive responses in several genotoxicity cell culture assays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393621     DOI: 10.1016/s1383-5718(97)00113-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Evaluation of extracts from Coccoloba mollis using the Salmonella/microsome system and in vivo tests.

Authors:  Marcela Stefanini Tsuboy; Juliana Cristina Marcarini; Dalva Trevisan Ferreira; Elisa Raquel Anastácio Ferraz; Farah Maria Drumond Chequer; Danielle Palma de Oliveira; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Genet Mol Biol       Date:  2010-09-01       Impact factor: 1.771

Review 2.  Marine Anthraquinones: Pharmacological and Toxicological Issues.

Authors:  Giulia Greco; Eleonora Turrini; Elena Catanzaro; Carmela Fimognari
Journal:  Mar Drugs       Date:  2021-05-13       Impact factor: 5.118

3.  Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures.

Authors:  C-Y Hsiang; T-Y Ho
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

4.  Anthraquinones: Genotoxic until Proven Otherwise? A Study on a Substance-Based Medical Device to Implement Available Data for a Correct Risk Assessment.

Authors:  Veronica Cocchi; Sofia Gasperini; Monia Lenzi
Journal:  Toxics       Date:  2022-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.